Overview

Pump.science is a Solana-based protocol that finances decentralized-science research into longevity compounds by gamifying the funding step. It is a spin-off of the memecoin launchpad pump.fun: instead of launching a joke coin, a researcher launches a token that stands for a specific real-world compound, and the trading demand for that token pays for the compound to actually be tested in a lab (Unchained). It launched in November 2024 and its first two experiments, $RIF and $URO, briefly became two of the most-watched tokens in crypto, drawing wide attention to DeSci as a category.

Pump.science matters to a DAO reference because it is the sharpest live example of a funding model the rest of the field treats cautiously: market speculation as the grant committee. Where a research DAO like VitaDAO deliberates over which projects to fund, Pump.science lets an open market decide by buying — and it wires that market directly to a bench experiment.

How a compound becomes a tradeable experiment

The pipeline is deliberately simple. A compound is issued as a token on pump.fun's bonding curve. According to founder Paul Kohlhaas, once a compound's token crosses a $10,000 market cap, "the experiment data is deployed live on Pump Science" — the trading interest has cleared the (very low) bar to fund a real trial, and results then stream back against the token (Unchained). Because a single automated experiment costs on the order of $300, even a modest speculative market can bankroll a full run.

The result is a feedback loop unlike anything in traditional grant funding: attention becomes capital, capital becomes an experiment, and the experiment's data feeds back to the people holding the token. Its critics note the obvious hazard — the same loop rewards hype over rigor, and a compound's token price is not evidence about the compound.

RIF and URO: the first two experiments

$RIF represents rifampicin, an antibiotic being screened for whether it slows aging in model organisms; $URO represents urolithin A, a pomegranate-derived compound studied for cellular "clean-up" (mitophagy). Both launched in November 2024 and spiked violently — on 18 November 2024, RIF's token reached roughly a $227M market cap and URO around $112M, each up tens of thousands of percent over the prior week (Unchained).

Those valuations then fell sharply from their peaks, and the team said it would focus on RIF and URO — running mouse experiments before introducing any new compound tokens, and pausing further launches until security audits of the application and smart contracts were complete (ChainCatcher). The episode is now a standard case study in how a gamified funding mechanism can pull enormous capital and attention into obscure geroscience overnight — and how quickly that attention leaves.

The lab layer: WormBot and FlyBox

What separates Pump.science from a pure memecoin is that the experiments are real and outsourced to specialist labs. Compounds are screened in worms (C. elegans) at Ora Biomedical on its WormBot, and in fruit flies at Tracked Biotechnologies on its FlyBox (Unchained). Ora Biomedical describes the WormBot as "a high-throughput robotics platform combined with neural net AI to perform high-throughput health and survival analysis in worms," feeding a broader effort to screen compounds for lifespan extension at scale (Ora Biomedical).

This layer is why holders receive something other than price action: standardized survival-curve data on the compound their token names. It is also the honest limit of the model — worm and fly lifespan screens are early, exploratory signals, several translational steps removed from a human longevity claim.

Tokens, IP rights, and the BIO connection

Pump.science's tokens are pitched as more than speculation: they "represent real-world intellectual property governance rights to the underlying compounds' data and to the experiments being traded" (Unchained). That threads the platform into the wider Molecule / BIO Protocol ecosystem, since founder Paul Kohlhaas leads both. On 25 December 2024, BIO Protocol announced it would airdrop 50 million BIO tokens proportionally to existing RIF and URO holders, pending governance approval to bridge BIO to Solana (Bitget News).

So the token a speculator buys nominally carries a claim on a research asset — a design that borrows the IP-NFT logic Molecule pioneered for VitaDAO, but delivers it through a freely tradeable, meme-launchpad token rather than a deliberative DAO treasury.

Is Pump.science a DAO?

Not in the token-voting sense, and this reference says so plainly — much as it does for ResearchHub. Pump.science is a funding platform and market, not a governed organization: there is no proposal-and-vote treasury steering the protocol, and the decisive mechanism is a price crossing a threshold, not a member vote. Its tokens confer nominal IP-governance rights over specific experiments, but "which compound gets funded" is decided by open-market buying, not by governance.

It earns a place in the DAO-industry directory precisely as the boundary case: the point where DeSci funding stops looking like a DAO and starts looking like a prediction-and-speculation market wired to a lab bench. That makes it the most useful contrast in the BioDAO set for thinking about who should actually control community-funded research.

How Caper approaches this

Pump.science and Caper sit at opposite poles of one question: how much of a community-funded effort's steering should be for sale. Pump.science makes almost all of it tradeable — a compound gets funded when its freely transferable token clears a market-cap bar, so buying pressure is the allocation mechanism. Caper deliberately removes the decisive slice from the market: voting on a caper mints a soulbound, non-transferable proof-of-vote token (indivisible, and locked to its holder — its deposit authority is the component itself, with updates permanently denied, per contracts/core/src/caper_dao.rs). A member's on-chain weight is compute_vote_weight = (t·v)/(V·T) in contracts/logic/src/lib.rs — their token holdings times their earned votes, over the totals — and that same weight sets each member's exit redemption before the vote tokens are burned.

The honest read is that each optimizes for something real. Pump.science maximizes liquid, permissionless attention — its whole thesis is that an open market can fund obscure science faster than any committee. Caper's earned, un-sellable weight is built for the opposite case: when you specifically do not want who-decides to be purchasable, and you want the people steering to be the ones who can't simply cash out of the consequences.